PT-141

Size: 10 mg

PT-141
$37.49$29.9920% OFF

BUNDLE & SAVE

1

Checking express payment options…

Earn 299 points with this option — 100 points per $10 spent. 500 points = $1 off.

Disclaimer: Our peptides are research-grade products for laboratory use only. They are not approved for human consumption or medical use. Always follow proper laboratory safety protocols.

Research Application Guidelines

This material is intended solely for controlled in vitro laboratory research performed by trained professionals. It is not approved for human or veterinary use and must not be incorporated into foods, pharmaceuticals, cosmetics, or diagnostic applications.


Regulatory Notice

This compound has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. All handling, storage, and research activity must comply with institutional policies and regulatory standards.


Purchase & Responsibility Agreement

All purchases from VoidResearch are final. By completing this transaction, the buyer confirms they are a qualified researcher or authorized laboratory and accepts full responsibility for lawful use, proper storage, and compliance with all applicable regulations.

Compound Information

Technical specifications & Research Data

MOLECULAR PROFILE

Bremelanotide (PT-141)

A cyclic heptapeptide melanocortin receptor agonist (MC4R-preferential), studied for central nervous system signaling in research models.

TypeCyclic synthetic peptide
CAS Number189691-06-3
Molecular Weight1,025 g/mol
Amino Acids7 (cyclic)
MC4R-Preferential Agonist
STORAGE REQUIREMENTS

Stability Info

Maintain optimal storage conditions

Lyophilized (powder)
Reconstituted
Light sensitivePotency Stable
COMPLIANCE

Research Notice

Strictly for laboratory use

This compound is not approved for human consumption. All data presented is sourced from clinical trials for educational reference only.
PURCHASE AGREEMENT

By purchasing, you confirm authorized laboratory status.

SOURCES & REFERENCES
Obstetrics & Gynecology (2019)
Bremelanotide for HSDD in Premenopausal Women (Kingsberg SA et al.)
View Publication
Journal of Sexual Medicine (2016)
Melanocortin Agonists and Central Signaling
View Publication
Peptides (2020)
MC4R Ligands: Pharmacology and Research Applications
View Publication

tested before it ships.
Proven purity 99%+.
Potent and reliable.

8× testedbefore it ships
Proven purity99%+
Potentand reliable
Shop Now

Research updates from Void Research

Subscribe for catalog updates, new research compounds, and quality documentation news

For researchers and labs. No spam, unsubscribe anytime.